Decision Diagnostics Corp DECN

Decision Diagnostics Corp. is specialized in prescription, non-prescription diagnostics and home testing products. The Company is a provider of prescription drugs, home testing products for the chronically ill, a fulfillment provider of direct to patient diabetes programs, and a developer of cell phone centric, e-health products and technology. Through its subsidiary, PharmaTech Solutions, Inc., the Company provides blood glucose home testing devices like GenUltimate! and PetSure! test strips and GenUltimate!4Pets monitoring system. It also provides smart phone based electronic medical record (EMR) applications to be used by physicians at the point of care. These mobile applications allow physicians to access and update their patients’ histories, medication data and care guidelines. The Company develops products that offer solutions to medical care professionals and management by providing physicians with essential information at their fingertips.

GREY:DECN - Post by User

Decision Diagnostics Corp > DECN Files Finalized FDA EUA Application

<< Previous

Bullboard Posts

Next >>

Post by homeygon Apr 06, 2020 11:53am

353 Views

Post# 30883132

DECN Files Finalized FDA EUA Application

$DECN News April 06, 2020 DECN Files Finalized FDA EUA Application for Its Genviro! Covid-19 Swift Kit, Receives Notification of Acceptance from FDA After-Hours on Friday 4/3/2020 https://www.accesswire.com/583960/DECN-Files-Finalized-FDA-EUA-Application-for-Its-Genviro-Covid-19-Swift-Kit-Receives-Notification-of-Acceptance-From-FDA-After-Hours-on-Friday-432020?Fid=DECN&Filter=DECN See the Corporate profile: https://www.thestreetnow.com/spotlight/decn/

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program